ROCK1 and acute myeloid leukemia: Inhibition of the downstream effector of Rho GTPases, ROCK1, by fasudil, H-1152 (dimethylfasudil), or Y27632 resulted in antiproliferative effects on cancer cells suggesting its promise as an AML treatment [44,62,63].